BCom BCom - Aspen Pharmacare Group Advisor
| APNHFDelisted Stock | USD 12.25 0.00 0.00% |
Insider
BCom BCom is Group Advisor of Aspen Pharmacare Holdings
| Age | 61 |
| Phone | 27 31 580 8600 |
| Web | https://www.aspenpharma.com |
Aspen Pharmacare Management Efficiency
The company has return on total asset (ROA) of 0.0499 % which means that it generated a profit of $0.0499 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.095 %, meaning that it generated $0.095 on every $100 dollars invested by stockholders. Aspen Pharmacare's management efficiency ratios could be used to measure how well Aspen Pharmacare manages its routine affairs as well as how well it operates its assets and liabilities.Aspen Pharmacare Holdings has accumulated 105 M in total debt with debt to equity ratio (D/E) of 0.38, which is about average as compared to similar companies. Aspen Pharmacare Holdings has a current ratio of 1.92, which is within standard range for the sector. Debt can assist Aspen Pharmacare until it has trouble settling it off, either with new capital or with free cash flow. So, Aspen Pharmacare's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Aspen Pharmacare Holdings sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Aspen to invest in growth at high rates of return. When we think about Aspen Pharmacare's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Found 2 records | INSIDER Age | ||
| Dominic KingSmith | Crescita Therapeutics | N/A | |
| Francois Lafortune | Crescita Therapeutics | N/A | |
Management Performance
| Return On Equity | 0.095 | |||
| Return On Asset | 0.0499 |
Aspen Pharmacare Holdings Leadership Team
Elected by the shareholders, the Aspen Pharmacare's board of directors comprises two types of representatives: Aspen Pharmacare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aspen. The board's role is to monitor Aspen Pharmacare's management team and ensure that shareholders' interests are well served. Aspen Pharmacare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aspen Pharmacare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sean Capazorio, Group Director | ||
| Lorraine Hill, Group Pharmacist | ||
| Zizipho Mmango, Group Officer | ||
| Carnie Linde, Group Head | ||
| BCom BCom, Group Advisor | ||
| ACIS BProc, Group Sec | ||
| Dip MBA, Group Officer | ||
| Stavros Nicolaou, Group Trade | ||
| Trevor Ziman, Regional Pacific | ||
| Stephen Saad, Group CEO, Founder, Executive Director |
Aspen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Aspen Pharmacare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.095 | |||
| Return On Asset | 0.0499 | |||
| Profit Margin | 0.17 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 4.58 B | |||
| Shares Outstanding | 444.95 M | |||
| Shares Owned By Insiders | 19.32 % | |||
| Shares Owned By Institutions | 60.77 % | |||
| Price To Earning | 11.83 X | |||
| Price To Book | 0.98 X |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Consideration for investing in Aspen Pink Sheet
If you are still planning to invest in Aspen Pharmacare Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aspen Pharmacare's history and understand the potential risks before investing.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Stocks Directory Find actively traded stocks across global markets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |